The Patent Finder

Pentech Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Pentech Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Pentech Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 6,193,992Female sexual dysfunction treatment
Lapsed on the fee record
Ended Feb 27, 2013 · From the USPTO record
Lapsed on the fee recordEnded Feb 27, 2013From the USPTO record
US 6,660,298Paroxetine tablets and capsules
Lapsed on the fee record
Ended Dec 9, 2011 · From the USPTO record
Lapsed on the fee recordEnded Dec 9, 2011From the USPTO record
US 6,638,948Amorphous paroxetine composition
Lapsed on the fee record
Ended Oct 28, 2011 · From the USPTO record
Lapsed on the fee recordEnded Oct 28, 2011From the USPTO record
US 6,306,437Apomorphine-containing dosage forms for ameliorating male erectile dysfunction
Lapsed on the fee record
Ended Oct 23, 2009 · From the USPTO record
Lapsed on the fee recordEnded Oct 23, 2009From the USPTO record
US 6,200,983Dosage forms containing apomorphine for ameliorating male erectile dysfunction
Lapsed on the fee record
Ended Mar 13, 2009 · From the USPTO record
Lapsed on the fee recordEnded Mar 13, 2009From the USPTO record
US 6,121,276Apomorphine-containing dosage forms for ameliorating male erectile dysfunction
Lapsed on the fee record
Ended Sep 19, 2008 · From the USPTO record
Lapsed on the fee recordEnded Sep 19, 2008From the USPTO record
US 6,087,362Apomorphine and sildenafil composition
Lapsed on the fee record
Ended Jul 11, 2008 · From the USPTO record
Lapsed on the fee recordEnded Jul 11, 2008From the USPTO record
US 6,566,368Apomorphine-containing dosage form for ameliorating male erectile dysfunction
Lapsed on the fee record
Ended May 20, 2007 · From the USPTO record
Lapsed on the fee recordEnded May 20, 2007From the USPTO record
US 6,503,927Amorphous paroxetine composition
Lapsed on the fee record
Ended Jan 7, 2007 · From the USPTO record
Lapsed on the fee recordEnded Jan 7, 2007From the USPTO record
US 5,562,917Transdermal administration of apomorphine
Term ended
Term ended no later than Oct 8, 2016 · Low confidence
Term endedTerm ended no later than Oct 8, 2016Low confidence
10 of 19 patents shown.
Pro members see all 19.
Pro members: see all 19 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited